The pharmacokinetics, pharmacodynamics and safety of oral doses of ilaprazole 10, 20 and 40 mg and esomeprazole 40 mg in healthy subjects: a randomised, open-label crossover study-Reference-Cited by-同舟云学术

The pharmacokinetics, pharmacodynamics and safety of oral doses of ilaprazole 10, 20 and 40 mg and esomeprazole 40 mg in healthy subjects: a randomised, open-label crossover study

Published:2014-07 Issue: Volume: Page:n/a-n/a
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Shin J. S.¹,Lee J. Y.¹²,Cho K. H.¹,Park H. L.¹,Kukulka M.³,Wu J.-T.³,Kim D. Y.¹,Park S.-H.⁴

Affiliation:

1. Central Research Institute; IL-YANG Pharmaceutical Co., Ltd.; Yongin South Korea

2. Department of Chemistry; Graduate School; Kyung Hee University; Suwon South Korea

3. Takeda Development Center Americas, Inc.; Deerfield IL USA

4. Division of Gastroenterology; Department of Internal Medicine; The Catholic University of Korea; Seoul South Korea

Funder

TAP Pharmaceutical Products Inc.

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.12860/fullpdf

Reference18 articles.

1. Night-time gastro-oesophageal reflux disease: prevalence, hazards, and management;Orr;Eur J Gastroenterol Hepatol,2005

2. The impact of nocturnal symptoms associated with gastroesophageal reflux disease on health-related quality of life;Farup;Arch Intern Med,2001

3. Nighttime heartburn is an under-appreciated clinical problem that impacts sleep and daytime function: the results of a Gallup survey conducted on behalf of the American Gastroenterological Association;Shaker;Am J Gastroenterol,2003

4. Proton pump inhibitors: an update;Vanderhoff;Am Fam Physician,2002

5. Acid inhibition effect of ilaprazole on Helicobacter pylori-negative healthy volunteers: an open randomized cross-over study;Du;J Dig Dis,2012

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Population pharmacokinetic modeling of ilaprazole in healthy subjects and patients with duodenal ulcer in China;Frontiers in Pharmacology;2024-01-10

2. Efficacy of Aceclofenac and Ilaprazole Combination Therapy versus Celecoxib Monotherapy for Treating NSAID-Induced Dyspepsia in Lumbar Spinal Stenosis Patients;Medicina;2023-07-14

3. A Pharmacogenetics-Based Approach to Managing Gastroesophageal Reflux Disease: Current Perspectives and Future Steps;Pharmacogenomics and Personalized Medicine;2023-06

4. A Comparison of Doxycycline and Amoxicillin Containing Quadruple Eradication Therapy for Treating Helicobacter pylori-Infected Duodenal Ulcers: A Multicenter, Opened, Randomized Controlled Trial in China;Pathogens;2022-12-16

5. Efficacy and safety of proton pump inhibitors versus vonoprazan in treatment of erosive esophagitis: A PRISMA-compliant systematic review and network meta-analysis;Medicine;2022-11-25